Skip to main content
    S

    Sera Prognostics Inc (SERA)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.00
    +0.06 (+3.09%)

    Market Cap: $79.94M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Sera Prognostics Inc (SERA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sera Prognostics (SERA) has a market cap of $79.94M and an enterprise value of $75.95M. It kept -34866.67% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 4.99% below the market cap, as cash exceeds debt.

    Market Cap$79.94M
    Enterprise Value$75.95M
    Latest price (Nov 17, 2026)$2.00

    Key Dates

    The next earnings report is expected on Mar 16, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 16, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.62% in the quarter ended Sep 30, 2026 and grew 23.09% a year over 2 years.

    Shares Outstanding50.79M
    Shares Change (YoY)+2.55%
    Shares Change (QoQ)+0.62%
    Share Count Growth (2Y CAGR)+23.09%

    Valuation Ratios

    Forward P/S399.7x
    P/B Ratio1.9x
    P/TBV Ratio2.0x

    Price Statistics

    The stock is down 32.43% over 52 weeks and trades 1.96% below its 50-day average.

    Beta (1Y)0.47
    52-Week Change-32.43%
    1-Month Change-1.48%
    3-Month Change+0.50%
    6-Month Change+14.94%
    5-Year Change-80.25%
    Total Return (1Y)-32.43%
    Total Return (3Y CAGR)+4.55%
    Total Return (5Y CAGR)-28.30%
    Return vs SPY (1Y)-47.46%
    Max Drawdown (1Y)-56.91%
    Max Drawdown (3Y)-87.25%
    Sharpe Ratio (1Y)-0.67
    Correlation with SPY (1Y)0.10
    50-Day Average$2.04
    200-Day Average$2.06
    52-Week Range$1.56 to $3.85
    RSI (14 Days)47.9
    Average Volume (20 Days)43.67K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.88x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.88x
    Quick Ratio1.88x
    Debt / Equity0.00x
    Interest Coverage-4780.71x

    Returns and Efficiency

    Return on equity is -63.83% over the last 12 months, against a 5-year average of -46.55%.

    Return on Equity (ROE)-63.83%
    Return on Assets (ROA)-41.85%
    Return on Capital Employed (ROCE)-60.35%
    ROE (5Y Average)-46.55%
    ROA (5Y Average)-35.28%
    ROIC (5Y Average)-33.44%
    Asset Turnover0.00x
    Receivables Turnover7.11x

    Scores

    SERA has an Altman Z-Score of -4.75, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-4.75
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $96.00K over the last 12 months is up 1.05% from the 12 months before.

    Revenue$96.00K
    Revenue Growth (YoY)+1.05%
    Gross Profit$96.00K
    Operating Income-$37.20M
    Pretax Income-$33.47M
    Net Income-$33.47M
    EBITDA-$32.37M
    EBIT-$33.47M
    Reported EPS (TTM)-$0.67

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 65.57% of the $79.98M in total assets.

    Cash and Equivalents$3.99M
    Total Debt$0
    Net Cash$3.99M
    Net Cash Per Share$0.08
    Working Capital$21.69M
    Shareholder Equity$52.44M
    Book Value Per Share$1.03
    Tangible Book Value$51.58M
    Tangible Book Per Share$1.02
    Total Assets$79.98M
    Total Liabilities$27.54M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $488.00K of capital spending, operating cash flow left -$28.99M of free cash flow.

    Operating Cash Flow-$28.50M
    Capital Expenditures$488.00K
    Free Cash Flow-$28.99M
    FCF Per Share-$0.75
    Depreciation and Amortization$1.10M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -38755.21%.

    Gross Margin100.00%
    Operating Margin-38755.21%
    Pretax Margin-34866.67%
    Net Margin-34866.67%
    EBITDA Margin-33715.63%
    EBIT Margin-34859.38%
    FCF Margin-30198.96%

    Growth

    Revenue fell 32.89% a year over 3 years.

    Revenue Growth (3Y CAGR)-32.89%
    Revenue Growth (5Y CAGR)+26.51%
    Book Value Per Share Growth (2Y CAGR)-17.81%
    Tangible Book Per Share Growth (2Y CAGR)-18.30%

    Revenue and profit by year

    Dividends and Yields

    SERA does not pay a dividend. Its free cash flow yield is -28.54%.

    FCF Yield-28.54%
    Buyback Yield-0.13%
    Shareholder Yield-0.13%

    Analyst Forecast

    Consensus estimates put revenue growth at 405.12% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+405.12%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SERA

    What is SERA's market cap?

    Sera Prognostics has a market cap of $79.94M. Its enterprise value, which adds debt and subtracts cash, is $75.95M.

    How many shares of SERA are outstanding?

    Sera Prognostics has 50.79M shares outstanding. The count is up 2.55% from a year earlier.

    Does SERA pay a dividend?

    No. Sera Prognostics does not pay a dividend.

    How much debt does SERA have?

    Sera Prognostics has $0 of total debt and $3.99M of cash and equivalents, a net cash position of $3.99M.